In a report released today, David Adlington from J.P. Morgan maintained a Buy rating on Siemens Healthineers AG (SEMHF – Research Report), with a price target of EUR63.10. The company’s shares closed last Monday at $46.94.
According to TipRanks, Adlington is a 2-star analyst with an average return of 0.4% and a 44.83% success rate. Adlington covers the Healthcare sector, focusing on stocks such as Siemens Healthineers AG, Demant, and Koninklijke Philips.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Siemens Healthineers AG with a $59.26 average price target, representing a 26.25% upside. In a report released today, Jefferies also maintained a Buy rating on the stock with a EUR53.00 price target.
SEMHF market cap is currently $53.09B and has a P/E ratio of 24.97.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnotics, and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. Siemens Healthineers was founded on December 1, 2017 and is headquartered in Erlangen, Germany.